Managing anticoagulation in patients receiving implantable cardiac devices.

about

P2860

Q47262760-0B07C3CA-3225-41CB-8BDD-8EC7C3DC502B

P2860

Managing anticoagulation in patients receiving implantable cardiac devices.

Item

http://www.wikidata.org/entity/Q38552586

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Managing anticoagulation in patients receiving implantable cardiac devices.

@en

type

Item

label

Managing anticoagulation in patients receiving implantable cardiac devices.

@en

prefLabel

Managing anticoagulation in patients receiving implantable cardiac devices.

@en

P1476

Managing anticoagulation in patients receiving implantable cardiac devices.

@en

P2093

Neil Mangrolia

http://www.w3.org/2001/XMLSchema#string

Peter J Pugh

http://www.w3.org/2001/XMLSchema#string

Vikrant Nayar

http://www.w3.org/2001/XMLSchema#string

P2860

2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.

Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.

Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.

Guidelines on oral anticoagulation (warfarin): third edition--2005 update.

Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

P304

393-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.11.88

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26203472

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Managing anticoagulation in patients receiving implantable cardiac devices.

about

P2860

P2860

Managing anticoagulation in patients receiving implantable cardiac devices.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921